Literature DB >> 22297666

Dyslipidemia: a prospective controlled randomized trial of intensive glycemic control in sepsis.

Sylas B Cappi1, Danilo T Noritomi, Irineu T Velasco, Rui Curi, Tatiana C A Loureiro, Francisco G Soriano.   

Abstract

PURPOSE: Metabolic disturbances are quite common in critically ill patients. Glycemic control appears to be an important adjuvant therapy in such patients. In addition, disorders of lipid metabolism are associated with worse prognoses. The purpose of this study was to investigate the effects that two different glycemic control protocols have on lipid profile and metabolism.
METHODS: We evaluated 63 patients hospitalized for severe sepsis or septic shock, over the first 72 h of intensive care. Patients were randomly allocated to receive conservative glycemic control (target range 140–180 mg/dl) or intensive glycemic control (target range 80–110 mg/dl). Serum levels of lowdensity lipoprotein, high-density lipoprotein, triglycerides, total cholesterol, free fatty acids, and oxidized low-density lipoprotein were determined.
RESULTS: In both groups, serum levels of low-density lipoprotein, high-density lipoprotein, and total cholesterol were below normal, whereas those of free fatty acids, triglycerides, and oxidized lowdensity lipoprotein were above normal. At 4 h after admission, free fatty acid levels were higher in the conservative group than in the intensive group, progressively decreasing in both groups until hour 48 and continuing to decrease until hour 72 only in the intensive group. Oxidized low-density lipoprotein levels were elevated in both groups throughout the study period.
CONCLUSIONS: Free fatty acids respond to intensive glycemic control and, because of their high toxicity, can be a therapeutic target in patients with sepsis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22297666     DOI: 10.1007/s00134-011-2458-z

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  40 in total

Review 1.  Lewis A. Conner Memorial Lecture. Oxidative modification of LDL and atherogenesis.

Authors:  D Steinberg
Journal:  Circulation       Date:  1997-02-18       Impact factor: 29.690

2.  Relationship between insulin resistance and partially oxidized LDL particles in healthy, nondiabetic volunteers.

Authors:  M Carantoni; F Abbasi; F Warmerdam; M Klebanov; P W Wang; Y D Chen; S Azhar; G M Reaven
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-05       Impact factor: 8.311

Review 3.  Alterations in carbohydrate metabolism during stress: a review of the literature.

Authors:  B A Mizock
Journal:  Am J Med       Date:  1995-01       Impact factor: 4.965

4.  Glucose-insulin-potassium, free fatty acids and acute myocardial infarction in man.

Authors:  R O Russell; W J Rogers; J A Mantle; H G McDaniel; C E Rackley
Journal:  Circulation       Date:  1976-03       Impact factor: 29.690

Review 5.  Lipoproteins in inflammation and sepsis. II. Clinical aspects.

Authors:  Martina Wendel; Rüdiger Paul; Axel R Heller
Journal:  Intensive Care Med       Date:  2006-11-09       Impact factor: 17.440

6.  Changes in plasma free fatty acid levels in septic patients are associated with cardiac damage and reduction in heart rate variability.

Authors:  Antonio Carlos Nogueira; Victor Kawabata; Paolo Biselli; Marcelo Henrique Lins; Carla Valeri; Mauricio Seckler; Wagner Hoshino; Luiz Gonzaga Júnior; Marcia Martins Silveira Bernik; Juliana B de Andrade Machado; Marina Baquerizo Martinez; Paulo Andrade Lotufo; Elia Garcia Caldini; Edgair Martins; Rui Curi; Francisco Garcia Soriano
Journal:  Shock       Date:  2008-03       Impact factor: 3.454

7.  Potential role of poly(adenosine 5'-diphosphate-ribose) polymerase activation in the pathogenesis of myocardial contractile dysfunction associated with human septic shock.

Authors:  Francisco G Soriano; Antonio C Nogueira; Elia G Caldini; Marcelo H Lins; Ana C Teixeira; Sylas B Cappi; Paulo A Lotufo; Márcia M S Bernik; Zsuzsanna Zsengellér; Min Chen; Csaba Szabó
Journal:  Crit Care Med       Date:  2006-04       Impact factor: 7.598

8.  Effect of modified glucose-insulin-potassium on free fatty acids, matrix metalloproteinase, and myoglobin in ST-elevation myocardial infarction.

Authors:  Ajay Chaudhuri; David Janicke; Michael Wilson; Husam Ghanim; Gregory E Wilding; Ahmad Aljada; Paresh Dandona
Journal:  Am J Cardiol       Date:  2007-12-01       Impact factor: 2.778

9.  Toxicity of a soybean oil emulsion on human lymphocytes and neutrophils.

Authors:  Maria Fernanda Cury-Boaventura; Renata Gorjão; Thaís Martins de Lima; Tatiane Maria Piva; Carmem Maldonado Peres; Francisco Garcia Soriano; Rui Curi
Journal:  JPEN J Parenter Enteral Nutr       Date:  2006 Mar-Apr       Impact factor: 4.016

10.  Mouse CD36 has opposite effects on LDL and oxidized LDL metabolism in vivo.

Authors:  Vilayphone Luangrath; Mathieu R Brodeur; David Rhainds; Louise Brissette
Journal:  Arterioscler Thromb Vasc Biol       Date:  2008-04-24       Impact factor: 8.311

View more
  12 in total

Review 1.  Glycemic control, mortality, and hypoglycemia in critically ill patients: a systematic review and network meta-analysis of randomized controlled trials.

Authors:  Tomohide Yamada; Nobuhiro Shojima; Hisashi Noma; Toshimasa Yamauchi; Takashi Kadowaki
Journal:  Intensive Care Med       Date:  2016-09-16       Impact factor: 17.440

2.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  Acute Med Surg       Date:  2018-02-05

3.  Effect of a Probiotic Preparation (VSL#3) on CardiovascularRisk Parameters in Critically-Ill Patients.

Authors:  Sarvin Sanaie; Mehrangiz Ebrahimi-Mameghani; Ata Mahmoodpoor; Kamran Shadvar; Samad Ej Golzari
Journal:  J Cardiovasc Thorac Res       Date:  2013-06-27

Review 4.  The optimal target for acute glycemic control in critically ill patients: a network meta-analysis.

Authors:  Tomoaki Yatabe; Shigeaki Inoue; Masahiko Sakaguchi; Moritoki Egi
Journal:  Intensive Care Med       Date:  2016-09-29       Impact factor: 17.440

5.  Inhibition of lipogenesis reduces inflammation and organ injury in sepsis.

Authors:  Juan Pablo Idrovo; Weng-Lang Yang; Asha Jacob; Lana Corbo; Jeffrey Nicastro; Gene F Coppa; Ping Wang
Journal:  J Surg Res       Date:  2015-07-02       Impact factor: 2.192

6.  Palmitate differentially regulates the polarization of differentiating and differentiated macrophages.

Authors:  Fangming Xiu; Li Diao; Peter Qi; Michael Catapano; Marc G Jeschke
Journal:  Immunology       Date:  2015-11-12       Impact factor: 7.397

7.  The Japanese Clinical Practice Guidelines for Management of Sepsis and Septic Shock 2016 (J-SSCG 2016).

Authors:  Osamu Nishida; Hiroshi Ogura; Moritoki Egi; Seitaro Fujishima; Yoshiro Hayashi; Toshiaki Iba; Hitoshi Imaizumi; Shigeaki Inoue; Yasuyuki Kakihana; Joji Kotani; Shigeki Kushimoto; Yoshiki Masuda; Naoyuki Matsuda; Asako Matsushima; Taka-Aki Nakada; Satoshi Nakagawa; Shin Nunomiya; Tomohito Sadahiro; Nobuaki Shime; Tomoaki Yatabe; Yoshitaka Hara; Kei Hayashida; Yutaka Kondo; Yuka Sumi; Hideto Yasuda; Kazuyoshi Aoyama; Takeo Azuhata; Kent Doi; Matsuyuki Doi; Naoyuki Fujimura; Ryota Fuke; Tatsuma Fukuda; Koji Goto; Ryuichi Hasegawa; Satoru Hashimoto; Junji Hatakeyama; Mineji Hayakawa; Toru Hifumi; Naoki Higashibeppu; Katsuki Hirai; Tomoya Hirose; Kentaro Ide; Yasuo Kaizuka; Tomomichi Kan'o; Tatsuya Kawasaki; Hiromitsu Kuroda; Akihisa Matsuda; Shotaro Matsumoto; Masaharu Nagae; Mutsuo Onodera; Tetsu Ohnuma; Kiyohiro Oshima; Nobuyuki Saito; So Sakamoto; Masaaki Sakuraya; Mikio Sasano; Norio Sato; Atsushi Sawamura; Kentaro Shimizu; Kunihiro Shirai; Tetsuhiro Takei; Muneyuki Takeuchi; Kohei Takimoto; Takumi Taniguchi; Hiroomi Tatsumi; Ryosuke Tsuruta; Naoya Yama; Kazuma Yamakawa; Chizuru Yamashita; Kazuto Yamashita; Takeshi Yoshida; Hiroshi Tanaka; Shigeto Oda
Journal:  J Intensive Care       Date:  2018-02-02

Review 8.  Intensive insulin therapy for septic patients: a meta-analysis of randomized controlled trials.

Authors:  Fang Song; Liu-Jun Zhong; Liang Han; Guo-Hao Xie; Cheng Xiao; Bing Zhao; Yao-Qin Hu; Shu-Yan Wang; Chao-Jin Qin; Yan Zhang; Deng-Ming Lai; Ping Cui; Xiang-Ming Fang
Journal:  Biomed Res Int       Date:  2014-06-18       Impact factor: 3.411

9.  Year in review in Intensive Care Medicine 2012: I. Neurology and neurointensive care, epidemiology and nephrology, biomarkers and inflammation, nutrition, experimentals.

Authors:  Massimo Antonelli; Marc Bonten; Maurizio Cecconi; Jean Chastre; Giuseppe Citerio; Giorgio Conti; J Randall Curtis; Goran Hedenstierna; Michael Joannidis; Duncan Macrae; Salvatore M Maggiore; Jordi Mancebo; Alexandre Mebazaa; Jean-Charles Preiser; Patricia Rocco; Jean-François Timsit; Jan Wernerman; Haibo Zhang
Journal:  Intensive Care Med       Date:  2012-12-18       Impact factor: 17.440

10.  HDL-c levels predict the presence of pleural effusion and the clinical outcome of community-acquired pneumonia.

Authors:  M Saballs; S Parra; P Sahun; J Pellejà; M Feliu; C Vasco; J Gumà; J L Borràs; L Masana; A Castro
Journal:  Springerplus       Date:  2016-09-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.